SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Fetal hydrops – a review and a clinical approach to identifying the cause

Dempsey, E; Homfray, T; Simpson, JM; Jeffery, S; Mansour, S; Ostergaard, P (2020) Fetal hydrops – a review and a clinical approach to identifying the cause. Expert Opinion on Orphan Drugs, 8 (2-3). pp. 51-66. ISSN 2167-8707 https://doi.org/10.1080/21678707.2020.1719827
SGUL Authors: Dempsey, Esther Alice

[img] PDF Accepted Version
Restricted to Repository staff only until 24 January 2021.
Available under License ["licenses_description_publisher" not defined].

Download (536kB)

Abstract

Introduction: Fetal hydrops describes abnormal fluid accumulation in two or more extravascular fetal compartments. It is a poor prognostic sign in a fetus, and many will not survive to term. Fetal hydrops is a clinical sign rather than a diagnosis and has a multitude of different causes. Areas covered: This review focusses on non-immune fetal hydrops. We discuss in detail the most common aetiologies such as infection and chromosomal abnormalities and cover rarer presentations of congenital malformation and single-gene disorders. We present a decision tree for the investigation of affected pregnancies. Expert opinion: The current approach to the investigation of fetal hydrops largely revolves around identifying the abnormal pathophysiology via ultrasound imaging. We believe that as genomic testing of a pregnancy can be undertaken with increasing accuracy, speed, accessibility and at reduced cost, genetic testing will feature earlier in the future diagnostic pathway.

Item Type: Article
Additional Information: This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Orphan Drugs on 24/01/2020, available online: http://www.tandfonline.com/10.1080/21678707.2020.1719827.
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Expert Opinion on Orphan Drugs
ISSN: 2167-8707
Language: en
Dates:
DateEvent
13 February 2020Published
24 January 2020Published Online
20 January 2020Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
FS/18/78/33932British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
URI: http://openaccess.sgul.ac.uk/id/eprint/111645
Publisher's version: https://doi.org/10.1080/21678707.2020.1719827

Actions (login required)

Edit Item Edit Item